CoChat

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma

Open access
Puhr, Hannah Christina, Karner, Alexander, Taghizadeh, Hossein, Jomrich, Gerd, Schoppmann, Sebastian Friedrich, Preusser, Matthias, Ilhan-Mutlu, Aysegül · 2020 · Journal of Cancer Research and Clinical Oncology

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The clinical behaviour and outcome of young patients with gastroesophageal tumours (GET) is surmised to differ from older patients, yet data on the comparison of these two patient subgroups is scarce. This study focuses on the investigation of the clinical characteristics and survival outcome of younger-age people with GET, when compared to older patients. METHODS: Patients diagnosed with GET at the Medical University of Vienna between 2004 and 2016 were included in this study. Clinical parameters and the overall survival (OS) were compared between young (≤ 45 years) and elderly (≥ 65 years) patients. RESULTS: Among 796 patients, who were eligible for this analysis, fifty-eight patients (7%) were ≤ 45 years at the initial onset of the disease. These 58 young patients were then matched to elderly patients based on the gender, tumour stage, histology and tumour location. The number of metastatic lesions was significantly higher among young patients (p < 0.05). In a non-metastatic setting younger patients showed a significant longer OS than older patients (median 1226 versus 801 days, p = 0.028). Furthermore, young patients with extensive metastatic disease (2 or more metastatic site) had a significantly poorer OS than elderly patients (median 450 versus 646 days, p = 0.033). CONCLUSION: These results indicate that young patients might be diagnosed very late, which might lead to the development of a more aggressive disease compared to older patients, but a relatively long OS when diagnosed and treated in a non-metastatic setting. Thus, screening methods for younger patients might be considerable to enhance the outcome of young patients with GET.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00432-020-03302-x

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age. b Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age in an initially non-metastatic setting. c Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age with an initial metastatic disease. d Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age in a setting with 2 or more metastatic sites
Fig. 1 a Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age. b Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age in an initially non-metastatic setting. c Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age with an initial metastatic disease. d Kaplan-Meier survival curve of the overall survival in patients with upper GI tumour in younger versus older age in a setting with 2 or more metastatic sitesCC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 16

Metadata

Authors
Puhr, H. C., Karner, A., Taghizadeh, H., Jomrich, G., Schoppmann, S. F., Preusser, M., & Ilhan-Mutlu, A.
Affiliations
Comprehensive Cancer Center Vienna (AT)
Venue
Journal of Cancer Research and Clinical Oncology
Published
2020-07-02
Volume
146
Issue
12
Pages
3313-3322
ISSN
  • 0084-5353 (ISSN-L)
  • 0171-5216
  • 1432-1335
OpenAlex
W3040537958
Cited by
16
References
38
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 3 · 2021: 2
FWCI
0.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Cancer Research and Clinical Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Medizinische Universität Wien
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
young patients, elderly patients, age comparison, overall survival, metastasis, delayed diagnosis, cancer screening, clinical features
MeSH terms
Adult, Age Factors, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Female, Gastrointestinal Neoplasms, Humans, Male, Middle Aged, Treatment Outcome, Disease-Free Survival, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. https://app.cochat.ai/papers/10.1007/s00432-020-03302-x
The paper
Puhr, H. C., Karner, A., Taghizadeh, H., Jomrich, G., Schoppmann, S. F., Preusser, M., & Ilhan-Mutlu, A. (2020). Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-020-03302-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.